tezosentan has been researched along with Sepsis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goraca, A; Kleniewska, P; Kolodziejczyk, M; Kowalczyk, A; Skibska, B | 1 |
Arner, A; Boels, PJ; Oldner, A; Persson, B; Rossi, P; Weitzberg, E | 1 |
1 review(s) available for tezosentan and Sepsis
Article | Year |
---|---|
The role of endothelin-1 and endothelin receptor antagonists in inflammatory response and sepsis.
Topics: Animals; Bosentan; Cytokines; Endothelin Receptor Antagonists; Endothelin-1; Humans; Inflammation; Lipopolysaccharides; NF-kappa B; Oligopeptides; Peptides, Cyclic; Piperidines; Pyridines; Reactive Oxygen Species; Sepsis; Signal Transduction; Sulfonamides; Superoxides; Tetrazoles | 2015 |
1 other study(ies) available for tezosentan and Sepsis
Article | Year |
---|---|
Endotoxemic pulmonary hypertension is largely mediated by endothelin-induced venous constriction.
Topics: Animals; Ciprofloxacin; Endothelin-1; Female; Hypertension, Pulmonary; Lipopolysaccharides; Lung; Male; Pyridines; Respiratory Distress Syndrome; Sepsis; Swine; Tetrazoles; Vascular Resistance; Vasoconstriction; Vasodilator Agents | 2008 |